市場調査レポート
商品コード
1417538
ACE阻害薬市場レポート:2030年までの動向、予測、競合分析ACE Inhibitors Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ACE阻害薬市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
ACE阻害薬の動向と予測
世界のACE阻害薬市場は、2024年から2030年までのCAGRが3.2%で、2030年までに推定60億米ドルに達すると予想されます。この市場の主な促進要因は、高血圧関連疾患の増加、バイオ医薬品の開発・生産需要の高まり、心血管疾患改善のための研究開発活動の活発化などです。世界のACE阻害薬市場の将来は、心不全、高血圧、慢性腎臓病、糖尿病市場における機会によって有望視されています。
ACE阻害薬市場の洞察
Lucintelの予測では、高血圧治療薬としてのリシノプリル需要の増加、心臓発作後の生存率向上のためのリシノプリル使用の増加により、予測期間中リシノプリルが最大セグメントであり続ける。
北米は、アンジオテンシン変換酵素阻害剤に対する需要の増加、および阻害剤の改良を目的とした研究開発事業の拡大により、予測期間中も最大地域であり続けると思われます。
Q1.市場規模は?
A1.世界のACE阻害薬市場は、2030年までに推定60億米ドルに達すると予想されています。
Q2.市場の成長予測は?
A2.世界のACE阻害薬市場は、2024年から2030年にかけてCAGR 3.2%で成長すると予測されます。
Q3.市場の成長に影響を与える主な促進要因は?
A3.この市場の主な促進要因は、高血圧関連疾患の増加、バイオ医薬品の市場開拓・生産需要の増加、心血管疾患改善のための研究開発活動の増加です。
Q4.市場の主要セグメントは?
A4.ACE阻害薬の世界市場の将来は、心不全、高血圧、慢性腎臓病、糖尿病市場における機会によって有望視されています。
Q5.市場の主要企業は?
A5.ACE阻害薬の主要企業の一部は以下の通りです。
Q6.今後、最大となる市場セグメントは?
A6.Lucintelは、リシノプリルは高血圧治療薬としての需要が伸びていること、また心臓発作後の生存率向上のためにリシノプリルの使用が伸びていることから、予測期間中も最大セグメントであり続けると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は?
A7.北米は、アンジオテンシン変換酵素阻害薬に対する需要の増加、および阻害薬の改良を目的とした研究開発の拡大により、予測期間中も最大の地域です。
Q8.レポートのカスタマイズは可能?
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
ACE Inhibitors Trends and Forecast
The future of the global ACE Inhibitors market looks promising with opportunities in the heart failure, hypertension, chronic kidney disease, and diabetes markets. The global ACE Inhibitors market is expected to reach an estimated $6.0 billion by 2030 with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are rising rates of hypertension-related diseases, rising demand for biopharmaceutical product development and production, as well as, growing number of research and development activities for the improvement of cardiovascular diseases.
A more than 150-page report is developed to help in your business decisions.
ACE Inhibitors by Segment
The study includes a forecast for the global ACE Inhibitors by drug type, application, end use, and region.
List of ACE Inhibitors Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ACE Inhibitors companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ACE Inhibitors companies profiled in this report include-
ACE Inhibitors Market Insights
Lucintel forecasts that lisinopril will remain the largest segment over the forecast period due to the growing demand for lisinopril medications for the treatment of high blood pressure, as well as a growth in the use of lisinopril to improve survival after a heart attack.
North America will remain the largest region over the forecast period because of the increased demand for angiotensin-converting enzyme inhibitors, as well as the expansion of research and development operations aimed at generating improved inhibitors.
Features of the Global ACE Inhibitors Market
Market Size Estimates: Ace inhibitors market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Ace inhibitors market size by drug type, application, end use, and region in terms of value ($B).
Regional Analysis: Ace inhibitors market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug type, application, end use, and regions for the ACE Inhibitors market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ACE Inhibitors market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the ACE Inhibitors market size?
Answer: The global ACE Inhibitors market is expected to reach an estimated $6.0 billion by 2030.
Q2. What is the growth forecast for ACE Inhibitors market?
Answer: The global ACE Inhibitors market is expected to grow with a CAGR of 3.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the ACE Inhibitors market?
Answer: The major drivers for this market are rising rates of hypertension-related diseases, rising demand for biopharmaceutical product development and production, as well as, growing number of research and development activities for the improvement of cardiovascular diseases.
Q4. What are the major segments for ACE Inhibitors market?
Answer: The future of the global ACE Inhibitors market looks promising with opportunities in the heart failure, hypertension, chronic kidney disease, and diabetes markets.
Q5. Who are the key ACE Inhibitors market companies?
Answer: Some of the key ACE Inhibitors companies are as follows.
Q6. Which ACE Inhibitors market segment will be the largest in future?
Answer: Lucintel forecasts that lisinopril will remain the largest segment over the forecast period due to the growing demand for lisinopril medications for the treatment of high blood pressure, as well as a growth in the use of lisinopril to improve survival after a heart attack.
Q7. In ACE Inhibitors market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because of the increased demand for angiotensin-converting enzyme inhibitors, as well as the expansion of research and development operations aimed at generating improved inhibitors.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.